Neuropsychopharmacology
- Developmental and molecular contributions to contextual fear memory emergence in mice1 year ago
- Mediodorsal thalamus projection to medial prefrontal cortical mediates social defeat stress-induced depression-like behaviors1 year ago
- Reply to Bisol: Critical review and recommendations for enhancement of the article on novel neurosteroid therapeutics for postpartum depression1 year ago
- Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis1 year ago
- Effects of gene dosage and development on subcortical nuclei volumes in individuals with 22q11.2 copy number variations1 year ago
- Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors1 year ago
- GABA release from central amygdala neurotensin neurons differentially modulates ethanol consumption in male and female mice1 year ago
Journal of Psychopharmacology
- Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence3 years ago
- Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze3 years ago
- Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool3 years ago
- Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”3 years ago
- Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model3 years ago
- Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample3 years ago
- The low risk for early renal damage during lithium treatment has not changed over time3 years ago
European Neuropsychopharmacology
- New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging2 years ago
- A shared decision journey to bridge the gap between treatment recommendation and low adherence?2 years ago
- Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence2 years ago
- Treating major depressive disorder with mixed features2 years ago
- In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior2 years ago
- Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes2 years ago
- Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study2 years ago